Ranbaxy Diflucan Generic Launch Delayed Until July Under Court Ruling
This article was originally published in The Pink Sheet Daily
Executive Summary
Company's fluconazole ANDAs are subject to the six-month pediatric extension for Pfizer's patent on the antifungal, a federal court says.